Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103936717B reveals a novel Delafloxacin intermediate synthesis with improved purity and yield for reliable pharmaceutical intermediates supply chains.
Patent CN1022629C details a robust synthesis for broad-spectrum cephalosporins. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel PdCl2-catalyzed route for pyrido[2,3-d]pyrimidine compounds offers superior yield and purity. Ideal for cost-effective API manufacturing and scalable supply chains.
Novel PdCl2-catalyzed route for Palbociclib intermediate. High yield, mild conditions, scalable process for API manufacturing cost reduction.
Patent CN113214169B reveals a mild, high-yield route for pyrazine intermediates. Discover cost-effective manufacturing strategies for pulmonary hypertension drugs.
Patent CN1035669C reveals advanced synthesis for arylpyrrole intermediates. Enhances supply chain reliability and cost reduction in agrochemical manufacturing with scalable routes.
Novel preparation method for formoxyl rosuvastatin calcium intermediate. Mild conditions, high yield, scalable manufacturing for reliable supply chain partners.
Patent CN113979983A reveals a high-efficiency Rh-catalyzed hydrogenation route for Fidarestat intermediates, offering superior enantioselectivity and cost reduction for pharmaceutical manufacturing.
Novel patent CN114044758B details improved synthesis of triazolinone herbicide intermediate. Enhances yield and stability for cost-effective agrochemical manufacturing.
Novel copper-catalyzed route for ethiprole intermediate offers high yield and mild conditions for reliable agrochemical intermediate supply chains and cost efficiency.
Patent CN109912624B reveals a streamlined synthesis for Baloxavir key intermediates, offering significant cost reduction and improved supply chain reliability for pharmaceutical manufacturers.
Patent CN120923476A reveals a 2-step Ni-catalyzed route for Orforglipron intermediates, eliminating SFC resolution and enabling cost-effective manufacturing.
Novel Ni-catalyzed route for latanoprost intermediate ensures significant cost reduction and enhanced supply reliability for global pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN106749068A reveals a cost-effective Azosemide intermediate route with high purity and reduced waste, ensuring reliable supply chain stability.
Patent CN112321454B reveals a streamlined synthesis for Eltrombopag intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN106380441A reveals a cost-effective synthetic route for fexofenadine intermediates. Achieve high purity and scalable production for pharmaceutical supply chains.
Patent CN101817783B details a high-yield synthesis of Tolvaptan intermediates via optimized acid chloride activation, offering significant cost reduction in API manufacturing.
Novel Cu-catalyzed route for Flumatinib intermediate CN111763170A. Eliminates genotoxic impurities, reduces cost, ensures supply continuity for API manufacturing.
Novel patent CN103274962B offers concise route for Pralatrexate intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN114276406A reveals a streamlined synthesis for desoximetasone intermediates using fermentation-derived starting materials, offering superior yield and cost efficiency for pharmaceutical manufacturing.